DGFT notified regarding the amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet

Feb 07, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Finance & Taxation ComplianceThe Directorate General of Foreign Trade (DGFT) on February 06, 2025, notified regarding the amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.

It states that the standard Input Output Norms (SION) A-222 has been revised to affect Erythromycin Stearate tablets 250 mg. (each tablet contains erythromycin Stearate equivalent to 250mg of Erythromycin, with an immediate effect.

[Notification No. – 46/2024-25]

View Document 1

Bookmark

Related Updates

View More Related Updates


Alternate Text

Get updates on the go on RegUpdate Mobile App.

Alternate Text
✦ NEW  ·  AI ASSISTANT